Literature DB >> 31363177

Heart rate control using beta-blockers for heart failure with atrial fibrillation: more than enough is too much.

Takahiro Okumura1, Yuki Kimura2, Toyoaki Murohara2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31363177     DOI： 10.1038/s41440-019-0303-x

Source DB:  PubMed          Journal:  Hypertens Res        ISSN： 0916-9636            Impact factor:   3.872


× No keyword cloud information.
  9 in total

1.  Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure.

Authors:  Finlay A McAlister; Natasha Wiebe; Justin A Ezekowitz; Alexander A Leung; Paul W Armstrong
Journal:  Ann Intern Med       Date:  2009-06-02       Impact factor: 25.391

2.  Is heart rate important for patients with heart failure in atrial fibrillation?

Authors:  Damien Cullington; Kevin M Goode; Jufen Zhang; John G F Cleland; Andrew L Clark
Journal:  JACC Heart Fail       Date:  2014-04-30       Impact factor: 12.035

3.  Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities.

Authors:  E Braunwald
Journal:  N Engl J Med       Date:  1997-11-06       Impact factor: 91.245

4.  Outcomes of Rate-Control Treatment in Patients With Atrial Fibrillation and Heart Failure　- A Nationwide Cohort Study.

Authors:  Hee Tae Yu; Pil-Sung Yang; Hancheol Lee; Seng Chan You; Tae-Hoon Kim; Jae-Sun Uhm; Jong-Youn Kim; Hui-Nam Pak; Moon-Hyoung Lee; Boyoung Joung
Journal:  Circ J       Date:  2017-11-14       Impact factor: 2.993

5.  Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial.

Authors:  Michael Böhm; Karl Swedberg; Michel Komajda; Jeffrey S Borer; Ian Ford; Ariane Dubost-Brama; Guy Lerebours; Luigi Tavazzi
Journal:  Lancet       Date:  2010-09-11       Impact factor: 79.321

6.  Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

Authors:  M R Bristow; E M Gilbert; W T Abraham; K F Adams; M B Fowler; R E Hershberger; S H Kubo; K A Narahara; H Ingersoll; S Krueger; S Young; N Shusterman
Journal:  Circulation       Date:  1996-12-01       Impact factor: 29.690

7.  Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.

Authors:  Dipak Kotecha; Jane Holmes; Henry Krum; Douglas G Altman; Luis Manzano; John G F Cleland; Gregory Y H Lip; Andrew J S Coats; Bert Andersson; Paulus Kirchhof; Thomas G von Lueder; Hans Wedel; Giuseppe Rosano; Marcelo C Shibata; Alan Rigby; Marcus D Flather
Journal:  Lancet       Date:  2014-09-02       Impact factor: 79.321

8.  Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study.

Authors:  Renate B Schnabel; Lisa M Sullivan; Daniel Levy; Michael J Pencina; Joseph M Massaro; Ralph B D'Agostino; Christopher Newton-Cheh; Jennifer F Yamamoto; Jared W Magnani; Thomas M Tadros; William B Kannel; Thomas J Wang; Patrick T Ellinor; Philip A Wolf; Ramachandran S Vasan; Emelia J Benjamin
Journal:  Lancet       Date:  2009-02-28       Impact factor: 79.321

9.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur Heart J       Date:  2016-05-20       Impact factor: 29.983
  9 in total
  2 in total

1.  Heart rate fluctuation predicts mortality in critically ill patients in the intensive care unit: a retrospective cohort study.

Authors:  Qi Guo; Zhanchao Xiao; Maohuan Lin; Guiyi Yuan; Qiong Qiu; Ying Yang; Huiying Zhao; Yuling Zhang; Shuxian Zhou; Jingfeng Wang
Journal:  Ann Transl Med       Date:  2021-02

2.  Beta-blocker treatment in heart failure patients with atrial fibrillation: challenges and perspectives.

Authors:  Emmanouil Chourdakis; Ioanna Koniari; Dimitrios Velissaris; Grigorios Tsigkas; Nikolaos G Kounis; Neriman Osman
Journal:  J Geriatr Cardiol       Date:  2021-05-28       Impact factor: 3.327
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.